Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
2022-2026 Latin America Molecular Diagnostics Market Opportunities in 22 Countries - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Infectious, Genetic, Cancer, Forensic and Paternity Tests - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... Pipeline, Emerging Opportunities for Suppliers This new 22-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. The report is designed to help current suppliers and potential market entrants identify and ... Read More
-
2022-2026 Middle East Molecular Diagnostics Market Opportunities in 11 Countries - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Infectious, Genetic, Cancer, Forensic and Paternity Tests - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... Pipeline, Emerging Opportunities for Suppliers This new 11-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. The report is designed to help current suppliers and potential market entrants identify and ... Read More
-
2022-2026 Europe Molecular Diagnostics Market Opportunities in 38 Countries - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Infectious, Genetic, Cancer, Forensic and Paternity Tests - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... Emerging Opportunities for Suppliers This new 38-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. The report is designed to help current suppliers and potential market entrants identify and evaluate ... Read More
-
2022-2026 Asia-Pacific Molecular Diagnostics Market Opportunities in 18 Countries - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Infectious, Genetic, Cancer, Forensic and Paternity Tests - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... Emerging Opportunities for Suppliers This new 18-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. The report is designed to help current suppliers and potential market entrants identify and evaluate ... Read More
-
Global Cancer Survivorship Care Growth Opportunities
... States favors the cancer survivorship care market in the country. Several health IT companies are considering the use of electronic health records (EHRs) or cancer treatment systems for cancer survivors. The use of patient-reported outcomes ... Read More
-
U.K. Cell and Gene Therapy Research Challenges Market, by Therapy Type (Cell Therapy (Stem Cells, T Cells, Dendritic Cells, and NK Cells) and Gene Therapy (Germline Gene Therapy and Somatic Gene Therapy)), and by Indication (Dermatology, Musculoskeletal, Oncology, Immunology, Cardiology & Neurology, and Others) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... (Dermatology, Musculoskeletal, Oncology, Immunology, Cardiology & Neurology, and Others) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028 Cell therapy can be defined as the transfer of new cells into a patient’s body to ... Read More
-
Immune Checkpoint Inhibitors Market by Type (PD-1 Inhibitors, PD-L1 Inhibitors and CTLA-4 Inhibitor) and Application (Lung Cancer, Bladder Cancer, Melanoma, Hodgkin lymphoma and other application): Global Opportunity Analysis and Industry Forecast, 2021-2030
... checkpoint inhibitors market was valued at $29,803.71 million in 2020, and is projected to reach $1,40,890.10 million by 2030, registering a CAGR of 16.8% from 2021 to 2030 Checkpoint inhibitor is a type of drug ... Read More
-
Global Exosome Research Products Market Size study, by Application (Cancer Applications, Non-Cancer Applications), by Products & Services (Kits and Reagents, Instruments, Services), by End-Use (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Clinical Testing Laboratories) and Regional Forecasts 2021-2027
... Testing Laboratories) and Regional Forecasts 2021-2027 Global Exosome Research Products Market is valued at approximately USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than XX % ... Read More
-
Global Peptide and Anticoagulant Drug Market Size study, by by product (Hormonal, Antibiotic, ACE Inhibitor, Antifungal, Others) by Application (Diabetes, Infectious Diseases, Cancer, Osteoporosis, Cardiology, Gynaecology, Other Applications) and Regional Forecasts 2021-2027
... Anticoagulant Drug Market is valued at approximately USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than 3.3% over the forecast period 2021-2027. Peptides are a specific ... Read More
-
Stem Cells Market (Product Type: Adult Stem Cell, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell, and Others; Source: Autologous and Allogenic; Application: Regenerative Medicines [Neurology, Oncology, Cardiology, and Others] and Drug Discovery & Development; and End-user: Therapeutics Companies, Cell & Tissue Banks, Tools & Reagents Companies, and Service Companies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028
... and End-user: Therapeutics Companies, Cell & Tissue Banks, Tools & Reagents Companies, and Service Companies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028 Stem Cells Market – Scope of Report TMR’s report ... Read More
-
North America Cancer Vaccines Market- Growth, Trends, and Forecast(2022 - 2027)
... growth of the market are the increasing number of cancer cases, rising investments and government funding in the development of cancer vaccines, and technological developments in cancer vaccines. The incidence of cancer is increasing every ... Read More
-
Asia-Pacific Acute Myeloid Leukemia Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... number of clinical trials into new therapies for leukemia patients. In Japan, approximately 4,500 patients are being diagnosed with AML every year, according to a 2018 report by Astellas Pharma Inc. Moreover, the survey has ... Read More
-
Cancer Cachexia Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... by 2026, registering a CAGR of 4.47% during the forecast period. The outbreak of COVID-19 impacted the cancer cachexia market, as hospitals and healthcare services were significantly reduced due to social distancing measures enforced globally. ... Read More
-
Europe Colorectal Cancer Screening Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... growing burden of colorectal cancer, and increasing cancer prevention initiatives. According to the WHO (World Health Organization), in Europe, colorectal cancer is considered the second-most common cause of cancer death in men and women. It ... Read More
-
Asia-Pacific Cancer Vaccines Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... The incidence of cancer is increasing every year and it has been the major factor for the growth of the cancer vaccines market. According to Glocbocan, in 2018, there were around 774,323 new cases of ... Read More
-
Asia-Pacific Cancer Biomarkers Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... a paradigm shift in healthcare, from diagnosis, after the symptoms have appeared, to early diagnosis or risk assessment, especially in countries, such as China, India, Japan, etc. Cancer is one of the leading causes of ... Read More
-
Hairy Cell Leukemia Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... cell leukemia is characterized by the uncontrolled accumulation of lymphocytes by bone marrow. According to National Organization for Rare Disorders, approximately 600-800 new cases are diagnosed each year in the United States. Most of the ... Read More
-
Acute Lymphoblastic Leukemia Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... (ALL) globally. The number of new cases being recorded each year is around 1.7 per 100,000 men and women per year. It has been estimated by the American Cancer Institute that in 2019, there will ... Read More
-
Acute Myeloid Leukemia Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... factors propelling the growth of this market are high Incidence and prevalence of acute myeloid leukemia, advancements in pharmacology and molecular biology to promote drug development, and increasing investments in R&D by the pharmaceutical companies. ... Read More
-
North America Colorectal Cancer Screening Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... genetic tests, an increase in the prevalence of colorectal cancer, and increasing cancer prevention initiatives. The increasing incidence of colorectal cancer (CRC) is found to be the third most prevalent form of cancer. It accounts ... Read More
-
Nucleotides Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... studied is the growing demand for nucleotides from pharmaceuticals and Increased Demand due to the COVID-19 Outbreak. On the flip side, the high manufacturing cost of nucleotides are hindering the growth of the market. Key ... Read More
-
Colorectal Cancer Screening Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... pandemic is expected to have a significant impact on the market. Many countries are in lockdown and have suspended trade with other countries and implemented travel restrictions, which has led to the decline in healthcare ... Read More
-
Global Cancer Monoclonal Antibodies Market - 2021-2028
... to cancer cells, as they bind to the proteins on their surface and stimulate an immune response. Therefore, monoclonal antibodies are highly customizable due to its specific nature and can play a crucial role in ... Read More
-
United States Cancer Biomarkers Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... treatments for cancer in the country and increasing usage of biomarkers in drug development. The rising number of cancer cases is creating tremendous opportunities for market players. The major market players are focusing on R&D ... Read More
-
T-Cell Lymphoma Market - Growth, Trends, Covid-19 Impact, and Forecasts (2022 - 2027)
... by 2026, registering a CAGR of 8.25% during the period of 2021-2026. Due to the high transmission rate of COVID_19 and lack of treatment, many countries suffered, and they are continuing to bear a significant ... Read More
Research Assistance
